替索單抗

{{Infobox drug
| type = mab
| image = Vedotin_ADCs.svg
| image_class = skin-invert-image
| width =
| alt =
| caption =

| mab_type = mab
| source = u
| target = （Tissue factor, TF）

| pronounce =
| tradename = Tivdak
| Drugs.com =
| MedlinePlus =
| DailyMedID = Tisotumab vedotin
| pregnancy_AU =
| pregnancy_AU_comment =
| pregnancy_category= Contraindicated
| legal_EU = Rx-only
| legal_EU_comment = 並於2025年3月獲得歐盟核准。 美國食品藥品監督管理局將它歸類為。

參考文獻
外部連結
*
*
*
*